adrenal gland disease: A disease involving the adrenal gland.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
219 |
4. Check minimum number of eventsNone |
219 |
5. Include endpointsNone |
219 |
6. Filter based on genotype QC (FinnGen only) |
219 |
Control definitions (FinnGen only)
- Control exclude
- E4_ENDOGLAND
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- E27
- Name in latin
- Alia hyperfunctio adrenocorticalis
Similar endpoints
↥List of similar endpoints to
Other adrenocortical overactivity
based on the number of shared cases.
Similar with more cases:
- Other disorders of adrenal gland
- Exclusions for E4_PCOS_BROAD
- Disorders of other endocrine glands
- Endocrine, nutritional and metabolic diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 4574 | 3566 | 1002 |
| Only index persons | 3335 | 2615 | 720 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.09 | 0.10 | 0.03 |
| Only index persons | 0.08 | 0.10 | 0.03 |
| Median age at first event (years) | |||
| Whole population | 7.91 | 7.69 | 8.52 |
| Only index persons | 8.08 | 7.85 | 8.90 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 219 | 183 | 36 |
| Unadjusted period prevalence (%) | 0.05 | 0.06 | 0.02 |
| Median age at first event (years) | 14.57 | 8.40 | 45.90 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 191
- Matched controls
- 1911
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E27.0
ICD-10 Finland
Other adrenocortical overactivity
+∞
239.3
176
*
H02AB09
ATC
hydrocortisone; systemic
24.6
35.1
50
27
105
Kela drug reimbursment
Adrenal cortical hypofunction
+∞
27.8
26
*
H02AA02
ATC
fludrocortisone; oral
+∞
22.3
21
*
E27.1
ICD-10 Finland
Primary adrenocortical insufficiency
+∞
22.3
21
*
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
13.1
18.6
33
30
E27.4
ICD-10 Finland
Other and unspecified adrenocortical insufficiency
+∞
15.8
15
*
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
173.6
15.7
16
*
E30.1
ICD-10 Finland
Precocious puberty
+∞
12.6
12
*
BCA31
NOMESCO Finland
Endoscopic unilateral adrenalectomy
138.7
12.6
13
*
25508
ICD-8 Finland
Diseases of adrenal glands, Hyperfunctio adrenocorticalis alia
+∞
11.6
11
*
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
8.5
9.4
20
26
D35.0
ICD-10 Finland
Benign neoplasm: Adrenal gland
52.4
8.8
10
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
6.2
8.4
22
39
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
+∞
8.4
8
*
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
+∞
8.4
8
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.9
7.4
48
197
Z51.80
ICD-10 Finland
Manipulation of puberty development with hormone therapy
+∞
7.3
7
*
E24.9
ICD-10 Finland
Cushing syndrome, unspecified
+∞
7.3
7
*
E34.45
ICD-10 Finland
Abnormal growth increase
+∞
7.3
7
*
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
+∞
7.3
7
*
M05BA04
ATC
alendronic acid; oral
7.3
6.7
15
22
H02AB07
ATC
prednisone; oral
4.1
6.4
24
65
E27.2
ICD-10 Finland
Addisonian crisis
+∞
6.3
6
*
E24.8
ICD-10 Finland
Other Cushing syndrome
+∞
6.3
6
*
E66.01
ICD-10 Finland
Obesity due to excess calories
3.7
6.0
25
74
H03AA01
ATC
levothyroxine sodium; systemic
2.7
6.0
44
193
C03CA01
ATC
furosemide; systemic
3.2
6.0
31
109
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3035637) Corticotropin [Mass/volume] in Plasma
36
28
15.19
38.37
2.3
1.8
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
39
101
4.48
14.23
2.3
1.6
u/l
10.5
7.3
0.53
21
66
(3023323) Follitropin [Units/volume] in Serum or Plasma
41
111
4.31
14.13
2.0
1.5
iu/l
15.6
15.7
0.01
22
79
(3023368) Bacteria identified in Blood by Culture
57
302
2.20
5.69
6.9
4.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
66
378
2.07
5.36
7.8
3.7
ph
7.4
7.4
0.37
18
67
(1616796) Gas panel - Central venous blood
12
26
4.82
5.32
8.3
3.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
16
44
3.84
5.31
1.3
1.3
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
29
116
2.73
5.30
3.4
3.3
pmol/l
5.0
4.9
0.24
29
103
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
45
228
2.23
4.97
2.7
2.0
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
95
645
1.84
4.54
7.6
7.3
—
—
—
0
0
(4035726)
26
107
2.62
4.50
1.5
1.5
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
72
449
1.90
4.49
5.1
3.2
mmol/l
2.4
2.4
0.92
64
395
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
100
695
1.81
4.39
3.6
2.6
nmol/l
72.5
71.3
0.17
94
627
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
33
159
2.27
4.08
2.8
1.9
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
191
1651
2.23
3.93
6.1
4.2
mu/l
1.9
1.8
0.54
179
1536
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
32
156
2.23
3.85
2.8
1.9
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
127
975
1.72
3.74
7.6
7.1
e9/l
0.2
0.2
0.41
111
852
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
101
729
1.72
3.73
11.4
8.2
mmol/l
1.2
1.2
0.18
88
647
(3001604) Monocytes [#/volume] in Blood
123
942
1.70
3.61
7.1
6.7
e9/l
0.6
0.5
1.73
108
808
(3025941) Bacteria identified in Stool by Culture
23
101
2.43
3.50
1.5
1.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
21
89
2.50
3.44
11.9
2.6
mmol/l
1.2
1.2
0.98
21
80
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
14
48
3.05
3.36
1.6
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
14
48
3.05
3.36
1.6
1.4
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
122
944
1.66
3.35
7.1
6.7
e9/l
0.0
0.0
0.71
107
808
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
72
486
1.72
3.32
1.9
1.6
pmol/l
91.1
95.4
0.35
39
245
(3019198) Lymphocytes [#/volume] in Blood
126
986
1.65
3.28
6.9
6.6
e9/l
2.5
2.2
0.48
112
868
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
6
7
8.77
3.28
2.3
1.0
%
75.5
74.1
—
6
7
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
6
7
8.77
3.28
2.3
1.0
mu/l
478.8
284.6
—
6
7
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
169
1432
1.79
3.24
5.8
3.7
pmol/l
14.3
14.3
0.06
153
1302
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
95
695
1.65
3.21
7.6
6.0
umol/l
12.3
12.5
0.02
88
647
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
15
56
2.80
3.13
1.7
1.2
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
10
29
3.57
3.08
9.5
2.4
kpa
8.7
9.7
—
10
29
(3013290) Carbon dioxide [Partial pressure] in Blood
10
29
3.57
3.08
9.6
2.4
kpa
5.0
4.7
—
10
29
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
8
16
5.15
3.08
11.3
3.7
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
31
165
2.02
3.00
1.2
1.3
—
—
—
0
0
(3044889) 12 lead EKG panel
116
905
1.60
2.94
3.2
2.8
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
15
58
2.70
2.94
1.7
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
15
59
2.66
2.85
1.7
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
11
36
3.16
2.85
1.5
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
8
18
4.57
2.82
1.9
2.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
7
14
5.13
2.75
1.1
1.3
nmol/l
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
92
688
1.58
2.74
11.4
7.8
mmol/l
1.2
1.2
0.68
87
641
(3021440) Promyelocytes/100 leukocytes in Blood
22
106
2.20
2.74
3.9
4.8
%
0.0
0.1
—
8
25
(3006504) Eosinophils/100 leukocytes in Blood
114
899
1.56
2.67
7.5
6.7
%
2.6
2.8
0.18
109
843
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
7
15
4.78
2.62
2.0
2.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
20
4.11
2.59
2.0
1.8
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
32
182
1.89
2.57
1.6
1.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
6
11
5.57
2.56
1.2
1.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
58
394
1.64
2.54
3.0
2.5
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
132
1084
1.55
2.53
10.2
8.5
e9/l
4.3
3.8
1.67
116
920
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
34
199
1.84
2.50
8.4
6.9
mmol/l
1.9
0.8
1.64
26
151
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
7
16
4.48
2.49
1.4
1.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
7
16
4.48
2.49
1.1
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
8
21
3.91
2.49
1.9
1.9
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
56
379
1.64
2.48
3.4
3.1
ng/l
34.9
26.3
0.22
34
188
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
32
185
1.85
2.45
1.2
1.3
iu/ml
364.4
124.0
—
8
70
(3006922) Hepatitis E virus Ab [Presence] in Serum
6
12
5.11
2.42
1.0
1.1
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
22
112
2.07
2.40
8.0
7.8
kpa
14.2
14.1
0.02
22
107
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
22
112
2.07
2.40
7.9
7.8
kpa
5.5
5.1
0.67
22
107
(3025159) Blasts/100 leukocytes in Blood
21
105
2.11
2.40
4.0
4.8
%
0.0
0.0
—
8
21
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
51
340
1.65
2.39
2.5
3.1
mg/l
0.9
1.4
0.58
34
236
(3021901) Oxygen saturation in Capillary blood
8
22
3.73
2.39
5.2
3.9
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
13
53
2.54
2.32
2.2
2.9
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
13
4.71
2.28
1.3
2.0
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
13
4.71
2.28
1.3
2.0
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
13
4.71
2.28
1.3
2.0
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
162
1408
1.58
2.28
3.8
3.2
mmol/l
5.6
5.6
0.16
151
1287
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
7
18
3.98
2.27
1.1
1.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
9
29
3.19
2.25
1.0
1.0
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
132
1100
1.50
2.24
10.9
6.0
u/l
91.6
86.4
0.39
125
1022
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
81
613
1.51
2.19
4.8
3.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
21
109
2.02
2.19
3.7
4.4
%
0.4
0.5
—
7
21
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
30
3.08
2.17
2.0
1.8
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
23
124
1.96
2.17
1.3
1.3
miu/ml
288.7
293.6
—
10
60
(3017181) Myelocytes/100 leukocytes in Blood
22
117
1.98
2.15
4.0
4.5
%
0.5
0.7
—
8
30
(3019060) Gas panel - Arterial blood
12
49
2.53
2.14
3.7
5.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
12
49
2.53
2.14
1.3
1.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
12
49
2.53
2.14
1.3
1.0
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
18
89
2.11
2.13
3.0
1.7
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
14
280
0.47
2.09
1.6
1.5
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
38
243
1.68
2.08
3.8
4.2
ng/l
885.6
765.2
0.13
31
192
(3019309) Folate [Moles/volume] in Red Blood Cells
28
164
1.81
2.07
1.5
1.6
nmol/l
1346.0
1038.6
0.89
23
125
(3034770) Mitochondria Ab [Titer] in Serum
10
38
2.71
2.04
1.1
1.6
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
15
70
2.23
2.03
1.7
1.7
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
25
142
1.86
2.03
1.7
1.3
u/ml
173.2
380.9
0.63
25
134
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
9
32
2.89
2.02
1.8
1.3
—
—
—
0
0
(3026782) Osmolality of Urine
52
363
1.57
2.01
4.8
2.7
mosm/kgh2o
591.1
576.2
0.17
46
318
(3030467) Casts [#/volume] in Urine by Automated count
70
522
1.50
2.01
5.0
3.3
e6/l
0.3
0.3
0.19
57
381
(36304419) Bacteria [Presence] in Urine
70
524
1.49
1.97
5.0
3.2
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
11
4.62
1.95
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
11
4.62
1.95
1.0
1.0
—
—
—
0
0
(4062490)
6
16
3.82
1.95
1.7
1.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
32
199
1.71
1.94
3.4
2.4
mmol/l
2.5
2.4
0.91
27
164
(3000850) Epithelial cells [#/volume] in Urine
54
385
1.53
1.90
4.4
2.5
e6/l
8.4
8.5
0.02
48
339
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
15
73
2.13
1.85
1.7
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
8
29
2.82
1.81
1.0
1.1
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
12
54
2.29
1.77
4.6
3.8
%
43.5
53.0
0.44
12
54
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
6
145
0.40
1.72
1.2
1.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
14
69
2.10
1.68
2.6
1.6
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
124
1056
1.40
1.67
3.2
3.0
u/l
37.8
30.9
0.75
119
1006
(3016018) Differential panel - Cerebral spinal fluid
7
25
2.86
1.66
2.1
3.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
66
505
1.44
1.63
3.3
2.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
146
1284
1.41
1.60
3.4
3.1
mmol/l
1.3
1.2
1.41
139
1204
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
63
480
1.44
1.59
2.2
2.4
mg/l
2.7
2.7
0.11
58
412
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
137
1193
1.40
1.58
5.4
4.0
mmol/mol
37.9
38.0
0.04
131
1120
(40758558) Short blood count panel - Blood
65
499
1.43
1.57
10.4
7.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
15
3.39
1.53
1.4
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
15
3.39
1.53
1.4
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
15
3.39
1.53
1.4
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
15
3.39
1.53
1.4
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
6
21
2.91
1.51
1.0
1.0
—
—
—
0
0
(3000991) Gas panel - Venous blood
32
214
1.58
1.49
9.3
8.7
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
34
231
1.56
1.48
1.4
1.5
titre
514.3
400.9
—
7
47
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
16
3.17
1.44
1.4
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
16
3.17
1.44
1.4
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
6
22
2.77
1.44
1.3
2.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
22
2.77
1.44
1.2
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
10
46
2.23
1.42
2.7
2.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
12
60
2.06
1.41
2.1
2.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
72
573
1.38
1.40
5.0
3.2
e6/l
77.5
55.3
0.19
58
429
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
17
2.98
1.36
1.2
1.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
58
447
1.40
1.36
3.8
3.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
11
54
2.09
1.35
1.6
1.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
104
886
1.33
1.29
11.4
8.6
e9/l
0.0
0.0
0.00
86
702
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
8
35
2.33
1.28
1.1
1.0
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
58
452
1.39
1.27
6.0
5.2
inr
1.1
1.1
0.12
21
138
(3007164) IgA [Mass/volume] in Serum or Plasma
76
619
1.35
1.27
1.7
1.5
g/l
1.8
1.9
0.35
43
335
(3003694) ABO and Rh group [Type] in Blood
53
672
0.72
1.26
1.5
1.8
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
9
45
2.04
1.25
2.9
2.3
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
33
233
1.49
1.22
3.4
6.2
s
30.5
30.2
0.11
33
227
(3026389) Candida sp identified in Specimen by Organism specific culture
6
26
2.34
1.19
1.3
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
11
57
1.98
1.19
2.0
2.0
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
179
1664
1.41
1.17
22.1
13.4
%
13.6
13.3
2.02
172
1632
(3004789) Transferrin [Mass/volume] in Serum or Plasma
29
201
1.51
1.17
4.0
2.6
g/l
2.3
2.5
1.26
29
182
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
113
0.43
1.16
1.2
1.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
5
20
2.53
1.15
1.2
1.5
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
5
20
2.53
1.15
4.2
1.8
%
92.1
93.7
—
5
20
(3018095) Leukocytes [#/volume] in Urine
83
694
1.32
1.14
5.7
3.8
e6/l
17.8
66.8
2.92
60
456
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
11
58
1.94
1.14
10.4
10.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
16
96
1.72
1.13
3.0
3.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
8
40
2.04
1.13
5.6
3.4
%
53.9
54.4
—
8
40
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
14
81
1.78
1.12
1.3
1.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
5
21
2.41
1.09
2.6
3.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
13
74
1.80
1.09
1.4
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
68
556
1.32
1.09
3.6
2.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
28
196
1.49
1.09
3.0
1.7
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
7
32
2.23
1.09
3.0
10.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
148
1344
1.31
1.08
3.7
3.2
mmol/l
1.4
1.5
0.92
141
1254
(3021601) Nitrite [Presence] in Urine by Test strip
102
883
1.29
1.07
6.4
4.8
estimate
0.0
0.0
0.00
22
187
(3031040) Bacteria [#/volume] in Urine by Automated count
136
1223
1.30
1.06
5.3
4.0
—
264.9
—
0
16
(3038177) Helicobacter pylori Ab [Presence] in Serum
7
34
2.09
1.04
1.0
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
9
47
1.95
1.03
1.9
3.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
32
233
1.44
1.03
1.5
1.6
%
1.5
1.4
0.59
27
213
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
149
1360
1.30
1.01
3.9
3.3
mmol/l
4.4
4.6
1.10
143
1278
(40768793) Breast Pathology biopsy report
7
35
2.03
1.01
1.3
1.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
102
890
1.27
0.99
4.9
3.4
estimate
0.0
0.0
0.00
22
182
(4306422)
5
23
2.20
0.98
1.2
1.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
25
175
1.48
0.98
9.1
6.9
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
190
1799
1.42
0.98
20.1
10.7
mg/l
21.1
22.3
0.24
150
1327
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
149
1364
1.29
0.97
4.1
3.5
mmol/l
2.6
2.7
0.86
143
1269
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
48
595
0.75
0.96
2.1
2.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
9
51
1.80
0.96
1.1
1.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
37
281
1.38
0.95
5.4
4.0
mg/mmol
14.3
16.3
0.10
28
192
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
9
52
1.76
0.93
1.4
1.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
32
238
1.40
0.93
5.7
7.6
mmol/l
1.4
1.4
0.00
22
191
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
6
28
2.17
0.92
1.5
1.9
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
40
310
1.36
0.91
2.1
2.8
ug/g
136.9
86.3
0.54
27
238
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
7
130
0.52
0.91
1.4
1.7
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
6
29
2.10
0.90
1.7
4.3
—
—
—
0
0
(44790047)
6
29
2.10
0.90
1.3
2.3
—
—
—
0
0
(44806118)
6
29
2.10
0.90
1.3
2.3
—
—
—
0
0
(44790048)
6
29
2.10
0.90
1.3
2.3
—
—
—
0
0
(44790049)
6
29
2.10
0.90
1.3
2.3
—
—
—
0
0
(3020891) Body temperature
8
42
1.94
0.89
7.0
4.8
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
30
223
1.40
0.88
4.0
2.6
umol/l
12.2
14.2
0.70
30
210
(3019832) Treponema pallidum Ab [Presence] in Serum
39
492
0.75
0.87
1.7
1.8
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
101
890
1.25
0.87
4.9
3.3
estimate
0.0
0.0
0.00
22
180
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
79
677
1.26
0.87
1.6
1.7
u/ml
0.9
2.9
1.48
16
155
(3017143) Hepatitis C virus Ab [Presence] in Serum
41
322
1.34
0.86
1.8
1.5
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
30
224
1.39
0.86
11.9
10.6
mmol/l
24.5
24.8
0.20
30
224
(40768804) Tissue Pathology biopsy report
65
545
1.27
0.85
2.2
1.8
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
26
190
1.42
0.84
3.5
1.9
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
137
1253
1.25
0.84
5.0
3.7
mm/h
12.5
8.9
2.06
128
1148
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
15
97
1.59
0.84
1.3
1.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
146
1345
1.26
0.83
19.3
8.4
ml/min/173m2
96.1
98.0
0.34
120
1008
(1002224) Polysomnography panel
8
46
1.77
0.83
1.1
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
35
270
1.35
0.83
4.1
3.5
mg/l
98.2
118.5
0.16
29
186
(3029937) Albumin [Presence] in Urine by Test strip
57
472
1.28
0.82
5.8
3.3
estimate
0.1
0.0
0.48
22
186
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
40
316
1.33
0.81
3.3
3.1
e6/l
2.2
4.5
1.26
21
161
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
13
82
1.62
0.80
1.7
2.8
ml/min/173m2
68.0
85.8
—
6
31
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
10
59
1.73
0.77
1.4
1.9
—
—
—
0
0
(3015736) pH of Urine
82
715
1.23
0.76
4.3
3.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
86
755
1.23
0.75
2.5
2.0
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
24
177
1.40
0.74
9.8
6.7
mmol/l
24.3
24.1
0.12
24
177
(3022145) Colonoscopy Study observation
17
117
1.49
0.74
1.6
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
9
56
1.63
0.73
1.7
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
7
40
1.77
0.72
3.3
3.3
e9/l
3.5
4.1
—
7
40
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
26
1.94
0.71
3.8
2.0
—
—
—
0
0
(3019225) pH of Specimen
16
110
1.49
0.70
4.1
4.3
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
11
69
1.63
0.70
13.9
9.4
%
95.8
94.5
0.88
11
69
(3049717) Cytology report of Urine Cyto stain
5
27
1.87
0.69
1.4
2.3
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
32
252
1.32
0.67
2.7
2.3
u/l
3707.3
6002.0
0.25
12
98
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
7
43
1.65
0.67
1.7
1.9
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
5
28
1.80
0.66
1.4
1.5
—
—
—
0
0
(3002256) Pathology report gross observation
21
155
1.39
0.66
1.3
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
22
164
1.38
0.65
1.5
1.6
—
—
—
0
0
(3000492) Spirometry study
19
139
1.40
0.63
1.6
1.4
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
20
0.00
0.60
0.0
2.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
74
653
1.20
0.60
5.2
3.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
32
257
1.29
0.59
1.3
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
54
625
0.82
0.59
2.5
2.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
6
35
1.73
0.58
4.0
1.9
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
10
65
1.56
0.56
1.1
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
39
324
1.25
0.56
3.2
3.0
e6/l
1.1
1.0
0.07
20
168
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
6
37
1.64
0.56
1.3
1.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
11
157
0.68
0.53
1.2
1.2
—
—
—
0
0
(4010399)
14
100
1.43
0.53
1.6
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
60
679
0.84
0.52
2.4
2.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
13
93
1.42
0.49
1.2
1.8
—
—
—
0
0
(3003338) MCHC [Mass/volume]
177
1703
1.21
0.47
21.9
13.8
g/l
332.1
332.9
0.55
171
1689
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
29
238
1.25
0.47
3.8
2.9
ng/l
171.8
272.5
0.27
16
133
(3011288) Drugs identified in Urine by Screen method
20
156
1.31
0.47
3.4
3.0
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
31
257
1.24
0.46
1.3
1.2
u/ml
1.4
9.7
—
8
105
(3019150) Specific gravity of Urine by Refractometry
47
409
1.19
0.44
3.8
3.1
kg/l
1.0
1.0
0.77
12
57
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
15
113
1.35
0.44
3.2
2.5
—
—
—
0
0
(3013512) EKG study
37
315
1.21
0.44
3.4
2.9
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
20
158
1.29
0.43
10.8
3.4
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
13
96
1.38
0.42
13.1
13.3
mg/l
1.2
1.1
0.39
13
89
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.3
—
127.2
—
0
15
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(4027681)
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
0
17
0.00
0.41
0.0
1.1
—
224.8
—
0
17
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
5
34
1.48
0.40
1.6
4.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
34
396
0.83
0.40
1.6
1.5
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
3.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
22
179
1.25
0.39
1.8
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
22
179
1.25
0.39
1.2
1.6
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
86
794
1.14
0.38
4.5
4.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
9
69
1.32
0.37
1.3
1.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
14
178
0.77
0.36
1.6
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
39
442
0.86
0.34
2.4
2.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
12
91
1.34
0.34
1.6
1.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
6
47
1.28
0.32
1.3
1.9
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
6
47
1.28
0.32
1.2
2.0
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
7
53
1.33
0.31
1.0
1.1
—
0.2
—
0
18
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
7
54
1.31
0.30
3.0
2.5
nmol/l
0.6
0.5
—
7
45
(3037467) Urinalysis macro (dipstick) panel - Urine
132
1263
1.11
0.30
6.6
4.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
47
424
1.14
0.29
5.4
4.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
33
373
0.86
0.29
2.2
1.9
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
21
177
1.21
0.28
1.6
2.0
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
10
76
1.33
0.28
1.5
1.7
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
10
78
1.30
0.24
1.5
1.7
—
105.7
—
0
7
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
15
124
1.23
0.24
2.3
2.2
—
18.8
—
0
6
(3007461) Platelets [#/volume] in Blood
208
2054
1.25
0.24
26.3
15.6
e9/l
269.1
265.3
0.37
202
1989
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
29
257
1.15
0.23
1.3
1.2
iu/ml
52.9
19.9
—
7
67
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
10
125
0.79
0.23
1.1
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
54
499
1.11
0.23
2.2
2.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
18
210
0.84
0.23
3.3
2.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
10
79
1.28
0.22
1.5
1.7
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
18
209
0.85
0.22
3.3
2.3
—
—
—
0
0
(4281824)
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
10
0.00
0.21
0.0
1.4
—
5.8
—
0
10
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
0
10
0.00
0.21
0.0
1.6
—
5.7
—
0
10
(3024471) HLA-A [Type]
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
0
12
0.00
0.21
0.0
2.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
6
48
1.26
0.20
3.8
2.6
g/l
1.7
1.3
—
6
42
(3022621) pH of Urine by Test strip
9
115
0.77
0.20
1.8
2.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.1
—
1.0
—
0
8
(4211845)
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
18
207
0.86
0.20
3.3
2.3
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
11
90
1.23
0.19
1.0
1.2
u/ml
5.5
6.4
—
5
66
(3000764) Benzodiazepines [Presence] in Urine
18
206
0.86
0.19
3.3
2.3
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
7
62
1.13
0.17
1.4
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
23
206
1.13
0.16
1.0
1.1
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
208
2060
1.19
0.16
26.1
15.5
e12/l
4.6
4.5
1.54
201
1988
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
13
151
0.85
0.16
1.5
1.6
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
8
73
1.10
0.16
1.0
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
191
1884
1.11
0.15
16.0
9.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
13
149
0.86
0.14
1.2
1.2
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
208
2062
1.17
0.14
26.2
15.5
e9/l
7.5
6.8
2.71
200
1989
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
11
94
1.18
0.13
1.1
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
9
105
0.85
0.13
1.1
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
181
1785
1.08
0.13
20.8
12.3
%
39.3
39.2
0.09
155
1506
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
11
127
0.86
0.13
1.5
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
11
127
0.86
0.13
1.5
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
11
127
0.86
0.13
1.5
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
11
127
0.86
0.13
1.5
1.4
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
20
181
1.12
0.12
1.1
1.3
—
93.9
—
0
9
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
44
1.14
0.10
1.2
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
46
1.09
0.09
1.8
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
47
1.07
0.09
1.2
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
56
540
1.05
0.08
2.0
1.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
18
194
0.92
0.07
3.2
2.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
9
85
1.06
0.07
1.2
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
17
158
1.08
0.06
6.4
5.2
ug/l
5.2
1.9
0.53
17
136
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
12
131
0.91
0.06
6.6
4.9
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
51
495
1.04
0.05
5.5
2.8
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
11
120
0.91
0.05
4.7
5.1
%
27.2
22.5
—
6
61
(3001019) Free T4 and TSH panel - Serum or Plasma
11
101
1.09
0.04
1.2
1.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
11
117
0.94
0.02
2.4
2.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
44
433
1.02
0.01
1.7
1.7
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
11
104
1.06
0.01
1.4
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
10
102
0.98
0.00
1.4
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
10
102
0.98
0.00
1.4
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
11
111
0.99
0.00
1.2
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
167
1672
0.99
0.00
4.7
4.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
17
173
0.98
0.00
2.1
2.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
20
202
0.99
0.00
2.1
1.8
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
9
0.00
0.00
0.0
3.7
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
8
79
1.01
0.00
1.3
1.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
2.3
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
5.6
—
0
6
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
5
59
0.84
0.00
2.2
2.2
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
56.2
—
0
5
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
5
0.00
0.00
0.0
6.6
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
0
6
0.00
0.00
0.0
1.0
—
173.8
—
0
6
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
8
79
1.01
0.00
1.0
1.1
—
10.3
—
0
16
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
0
5
0.00
0.00
0.0
1.6
—
96.4
—
0
5
(3005593) Pancreatic islet cell Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
8
82
0.97
0.00
1.8
2.8
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
5.4
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
8.1
—
10.2
—
0
9
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
17
170
1.00
0.00
1.1
1.5
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
24.3
—
0.6
—
0
6
(3043410) Blood group antigens tested for on Red Blood Cells
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint E4_ADREACT and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| E4_ADREACT | 4.569 [3.1, 6.73] | < 0.001 |
| Birth year | 0.992 [0.98, 1.0] | 0.084 |
During the follow-up period (1.1.1998 — 31.12.2019), 65 out of 2952 females with E4_ADREACT died.
Males
No dataMortality risk
Mortality risk for people of age
years, who have E4_ADREACT.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.47% | No data |
| 5 | 2.272% | No data |
| 10 | 5.762% | No data |
| 15 | 11.548% | No data |
| 20 | 18.618% | No data |
Relationships between endpoints
↥Index endpoint: E4_ADREACT – Other adrenocortical overactivity
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data